302. Leber hereditary optic neuropathy Clinical trials / Disease details
Clinical trials : 22 / Drugs : 16 - (DrugBank : 4) / Drug target genes : 5 - Drug target pathways : 33
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02176733 (ClinicalTrials.gov) | July 2011 | 25/6/2014 | Trial of Cyclosporine in the Acute Phase of Leber Hereditary Optic Neuropathy | Leber Hereditary Optic Neuropathy | Drug: cyclosporine | University Hospital, Angers | NULL | Recruiting | 18 Years | N/A | Both | 12 | Phase 2 | France |